The U.S. FDA has granted orphan drug designation to Eisai's (OTCPK:ESALF) Lenvima (lenvatinib) for esophageal cancer. The ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

coli outbreak linked to raw onions served on McDonald's Quarter Pounders weeks ago has climbed, but there no longer appears to be any food safety concerns at the fast food giant's restaurants, ...

Opioid overdose deaths have decreased for 12 months, with 70,655 predicted deaths through June 2024, down from 86,401 in June ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

HUNTINGTON, W.Va. (WSAZ) - The U.S. Food and Drug Administration has authorized the first over-the-counter test that can ...

Part 3 of this series for Global Biosimilars Week, penned by Dracey Poore, director of biosimilars at Cardinal Health, ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Clinical development and trial testing of vesleteplirsen (SRP-5051) for Duchenne muscular dystrophy (DMD) was stopped, with ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...